EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Therapies for Glioblastoma

Stella Aimé Rios iD, Stephanie Oyervides, David Uribe, Angelica Maree Reyes, Victor Fanniel, Jonathan Vazquez, Megan Keniry iD

Cancers · 12.04.2024 · 16 (8) · 1485

DOI: 10.3390/cancers16081485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 12.04.2024. Verfasst von Stella Aimé Rios und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Biological and Chemical Sciences, College of Sciences, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIGMS, UTRGV Presidential Research Scholarships.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is most commonly a primary brain tumor and the utmost malignant one, with a survival rate of approximately 12–18 months. Glioblastoma is highly heterogeneous, demonstrating that different types of cells from the same tumor can manifest distinct gene expression patterns and biological behaviors. Conventional therapies such as temozolomide, radiation, and surgery have limitations. As of now, there is no cure for glioblastoma. Alternative treatment methods to eradicate glioblastoma are discussed in this review, including targeted therapies to PI3K, NFKβ, JAK-STAT, CK2, WNT, NOTCH, Hedgehog, and TGFβ pathways. The highly novel application of oncolytic viruses and nanomaterials in combating glioblastoma are also discussed. Despite scores of clinical trials for glioblastoma, the prognosis remains poor. Progress in breaching the blood–brain barrier with nanomaterials and novel avenues for targeted and combination treatments hold promise for the future development of efficacious glioblastoma therapies.

Schlagwörter

Stichwörter der Autor:innen

CK2EGFRFOXO1JAKLIFNFLβPI3KSTAT3glioblastomaoncolytic viruses

Autor:innen und Institutionen

  • School of Integrative Biological and Chemical Sciences, College of Sciences, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.

ORCID-Profile: Stella Aimé Rios, Megan Keniry

Förderung

  • NIGMS NIH HHS
  • NIGMS
  • UTRGV Presidential Research Scholarships

Zitieren

APA

Rios, S. A., Oyervides, S., Uribe, D., Reyes, A. M., Fanniel, V., Vazquez, J., & Keniry, M. (2024). Emerging Therapies for Glioblastoma. Cancers, 16(8), 1485. https://doi.org/10.3390/cancers16081485

Vancouver

Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J, et al. Emerging Therapies for Glioblastoma. Cancers. 2024;16(8):1485. doi:10.3390/cancers16081485

BibTeX
@article{Rios2024,
  author = {Rios, Stella Aimé and Oyervides, Stephanie and Uribe, David and Reyes, Angelica Maree and Fanniel, Victor and Vazquez, Jonathan and Keniry, Megan},
  title = {Emerging Therapies for Glioblastoma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {8},
  pages = {1485},
  doi = {10.3390/cancers16081485}
}
Kostenlos starten →